CUSIP: 65481J109
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,352,556
-
Share change
-
+1,217,996
-
Total reported value
-
$173,047,101
-
Price per share
-
$12.97
-
Number of holders
-
61
-
Value change
-
+$14,492,079
-
Number of buys
-
41
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 65481J109:
Institutional Holders of NIVALIS THERAPEUTICS INC - COM (NVLS) as of Q3 2015
As of 30 Sep 2015,
NIVALIS THERAPEUTICS INC - COM (NVLS) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,352,556 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, TIGER MANAGEMENT L.L.C., RA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, Rock Springs Capital Management LP, FRANKLIN RESOURCES INC, KINGDON CAPITAL MANAGEMENT, L.L.C., SABBY MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.